Action Alert: Urge Your Elected Officials to Co-Sponsor the DIVERSE Trials Act
Clinical trials are fundamental to the discovery of new and better therapies in the fight against ovarian cancer. Yet enrollment and widespread availability remain a challenge. To address both financial barriers and inequity in participation, OCRA is urging Congress to pass the DIVERSE (Diversifying Investigations Via Equitable Research Studies for Everyone) Trials Act (H.R. 5030/S. … Continued